The DOI matches its Crossref record.
Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Müllerian Hormone and Its Type II Receptor
Open accessAbstract
Anti-Müllerian hormone induces the regression of fetal Müllerian ducts and inhibits the transcription of gonadal steroidogenic enzymes. It belongs to the transforming growth factor-beta family whose members signal through a pair of serine/threonine kinase receptors and Smad effectors. Only the anti-Müllerian hormone type II receptor has been identified. Our goal was to determine whether anti-Müllerian hormone could share a type I receptor with another family member. Co-immunoprecipitation of known type I receptors with anti-Müllerian hormone type II receptor clearly showed that the bone morphogenetic protein type IB receptor was the only cloned type I receptor interacting in a ligand-dependent manner with this type II receptor. Anti-Müllerian hormone also activates the bone morphogenetic protein-specific Smad1 pathway and the XVent2 reporter gene, an anti-Müllerian hormone type II receptor-dependent effect abrogated by a dominant negative version of bone morphogenetic protein type IB receptor. Reverse amplification experiments showed that bone morphogenetic protein type IB receptor is co-expressed with anti-Müllerian hormone type II receptor in most anti-Müllerian hormone target tissues. Our data support a model in which a ligand, anti-Müllerian hormone, gains access to a shared type I receptor and Smad1 system through a highly restricted type II receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Self-citationInman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
The Bone Morphogenetic Protein System In Mammalian Reproduction
Shimasaki, S., Moore, R. K., Otsuka, F., & Erickson, G. F. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0007 · Cited by 741
Two major Smad pathways in TGF‐β superfamily signalling
Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., & Miyazono, K. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00599.x · Cited by 662
Wilson, T., Wu, X.-Y., Juengel, J. L., Ross, I. K., Lumsden, J. M., Lord, E. A., Dodds, K. G., Walling, G. A., McEwan, J. C., O’Connell, A. R., et al. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.4.1225 · Cited by 548
Divergence and convergence of TGF‐β/BMP signaling
Miyazono, K., Kusanagi, K., & Inoue, H. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1080 · Cited by 505
The transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Anti-Müllerian hormone and folliculogenesis
Visser, J. A., & Themmen, A. P. N. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.09.008 · Cited by 461
Requirement of Bmpr1a for Müllerian duct regression during male sexual development
Jamin, S. P., Arango, N. A., Mishina, Y., Hanks, M. C., & Behringer, R. R. (2002) · Nature Genetics · doi:10.1038/ng1003 · Cited by 399
Developmental genetics of the female reproductive tract in mammals
Kobayashi, A., & Behringer, R. R. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1225 · Cited by 397
La Marca, A., & Volpe, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02533.x · Cited by 369
Cooperative Inhibition of Bone Morphogenetic Protein Signaling by Smurf1 and Inhibitory Smads
Murakami, G., Watabe, T., Takaoka, K., Miyazono, K., & Imamura, T. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0441 · Cited by 328
Teixeira, J., Maheswaran, S., & Donahoe, P. K. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0445 · Cited by 326
Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa Cells
Moore, R. K., Otsuka, F., & Shimasaki, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207362200 · Cited by 326
Anti-Müllerian hormone and its receptors
Josso, N., di Clemente, N., & Gouédard, L. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00467-1 · Cited by 308
Self-citationAMH and AMH receptor defects in persistent Müllerian duct syndrome
Josso, N., Belville, C., di Clemente, N., & Picard, J.-Y. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi014 · Cited by 307
Self-citationAMH/MIS: what we know already about the gene, the protein and its regulation
Rey, R., Lukas-Croisier, C., Lasala, C., & Bedecarrás, P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.007 · Cited by 279
Metadata
- Authors
- Gouédard, L., Chen, Y.-G., Thevenet, L., Racine, C., Borie, S., Lamarre, I., Josso, N., Massagué, J., & di Clemente, N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 275
- Issue
- 36
- Pages
- 27973-27978
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2086484290
- Cited by
- 163
- References
- 0
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.